Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
2.250
+0.030 (1.35%)
At close: Apr 28, 2026, 4:00 PM EDT
2.230
-0.020 (-0.89%)
After-hours: Apr 28, 2026, 7:33 PM EDT
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $411.05 million as of April 28, 2026. Its market cap has increased by 272.73% in one year.
Market Cap
411.05M
Enterprise Value
283.53M
1-Year Change
272.73%
Ranking
Category
Stock Price
$2.25
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $411.05M, a decrease of -84.09%. That is a compound annual growth rate of -50.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 411.05M | 35.13% |
| Dec 31, 2025 | 304.19M | -82.24% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atea Pharmaceuticals | 427.04M |
| Neurogene | 422.41M |
| Lexeo Therapeutics | 416.74M |
| PureTech Health | 412.93M |
| Invivyd | 412.89M |
| Century Therapeutics | 405.13M |
| Armata Pharmaceuticals | 402.96M |
| Vanda Pharmaceuticals | 401.34M |